Skip to content


How will we use your donation?

The MOG Project is a Maryland-based official 501(c)3 non-profit organization devoted to our local, national and international MOGAD community.  As a 100% volunteer organization, our mission is to educate, support, and push for research in hopes of finding a cure.

However, we cannot do this without your help in providing funds.

NO donation is too small and will make a difference in the quality that we can provide.  Please consider a donation to help us help you!

Here are some of the areas where your donation has an impact:

  • Providing accurate and up-to-date information for education for MOGAD patients, caregivers and doctors.
  • Aiding researchers to collect important data for use and consideration in MOGAD research.
  • Raising funds (big or small) to support MOGAD and related research.
  • Addressing high volume concerns with renowned experts.
  • Providing awareness materials for support of MOGAD patients, promote our advocacy mission and bringing awareness to this rare disorder.

We have a few ways to help you donate:

Some Super-Easy Ways

Do you have the PayPal App on your smartphone?

Great!  Just use your PayPal app send to


Create your own personal Facebook Fundraiser!

We get 100% of your donation from facebook

Pro-tip: Using Facebook is completely cost-free for us AND you, so all of your $$ goes to where it will make the most impact!

Just create a fundraiser from our Facebook page:

Still Pretty Easy, Especially when you do a Recurrent Donation

Pay Here Using the form below.
This allows you to do a One-TIME donation or a Recurrent Donation.

Consider a Buck a Week!
No donation is too small

Donate to The MOG Project to support our mission:
Donation Period *
Kenny shows his Fear the Bird t-shirt under a rainbow of hope
Kenny shows off his Fear the Bird t-shirt under a rainbow of hope

Ways to Donate Directly to Research in Neuroimmunology

The MOG Initiative at the Neuroimmunology Clinic and Research Laboratory at Massachusetts General Hospital

Consider supporting The MOG Initiative at Massachusetts General Hospital. 

To donate directly to this effort please visit their donation page here.

To read more about Dr. Michael Levy’s MOG Initiative, please visit The MOG Initiative.

Jim Broutman's Foundation at The Mayo Clinic's Neuroimmunology Research Laboratory

After a horrific and serious bout of optic neuritis and transverse myelitis which was attributed to the MOG Antibody, our own Chief Media Officer, Jim Broutman, with the help of Dr. Sean Pittock, set up his own foundation allowing people to donate directly to the Mayo Clinic Neuroimmunology Research Laboratory specifically to support MOGAD research.  Please consider supporting this great effort in research, please follow the link below:

Join Jim Broutman in Supporting MOG IgG Associated Disorder Research at Mayo Clinic

Johns Hopkins Medicine Pilot Study for Effective MOGAD Treatments

This potential pilot project, created by Dr. Elias Sotirchos and his team, would analyze abnormal white blood cells in the blood and spinal fluid from people with MOGAD and compare them to the white blood cells of a control group. This study would gain insight into the mechanisms that cause the cell abnormality and potentially identify targets that would lead to the creation of therapeutic treatments for the MOG illness. In addition, with the data from this study, Dr. Sotirchos hopes to open the door to acquiring the additional funding needed to further the research of MOG on a larger scale.  Please consider supporting this great effort in research, by following the link below:

Join Audrey and Jim Wrenn in Supporting the Pilot Study for Effective MOGAD Treatments at Johns Hopkins Medicine

For those who prefer donations by Mail

Please send your check made out to The MOG Project and send to:

The MOG Project

P.O. Box 936

Olney, Maryland 20830-0936

Please provide a return address or email so that we can send a receipt for your tax records as all donations are tax-deductible

Pro-tip: also completely free for us, so more of your $$ goes to where it will make the most impact.


We know that your donations are a heartfelt contribution to our mission.  We are grateful for your donation and are committed to letting you know how your donations are used.

Massachusetts General Hospital
Harvard University

Michael Levy, MD, PhD

Dr. Levy is an Associate Professor in Neurology who was recently recruited to lead the new Neuroimmunology Division at the Massachusetts General Hospital. His mission is to build a combined clinical and research neuroimmunology program to develop therapies for patients with autoimmune diseases of the central nervous system. Dr. Levy moved from Baltimore, MD, where he was one of the faculty at Johns Hopkins University since 2009 and Director of the Neuromyelitis Optica Clinic.

Clinically, Dr. Levy specializes in taking care of children and adults with rare neuroimmunological diseases including neuromyelitis optica, transverse myelitis, MOG antibody disease and acute disseminated encephalomyelitis. In addition to four monthly clinics, Dr. Levy is the principal investigator on several clinical studies and drug trials for these conditions.

In the laboratory, Dr. Levy’s research focuses on four main areas:
1. Development of animal models of neuromyelitis optica (NMO) with the goal of tolerization as a sustainable long term treatment: His team generated a mouse model of NMO based on pathogenic T cells reactive against the aquaporin-4 water channel. Now, they are using this mouse model to create a tolerization therapy to desensitize the immune response to aquaporin-4.
2. Genetic basis of transverse myelitis: His team discovered a genetic mutation in VPS37a found in a group of patients with a familial form of transverse myelitis (TM). To understand how this gene is involved in this immune process, they generated a mouse model with this mutation.
3. The immunopathogenesis of MOG antibody disease: This may depend on a subset of T cells called gamma/delta T cells. These specialize T cells react to MOG in mouse models and attack the central nervous system. In addition to understanding why and how these T cells are involved in MOG antibody disease, they are developing a treatment to target these cells.
4. Biomarker assays for other autoimmune diseases of the central nervous system: They are developing assays that detect autoreactive T cells in NMO and MOG antibody disease. In parallel, they are screening for novel antibodies to glial cells in related disorders such as encephalitis and optic neuritis.